An ingenious targeted nanoparticle approach developed by Vanderbilt researchers reduced tumor burden in a model of ovarian cancer.
Vanderbilt researchers designed micelle “packets” to selectively deliver anti-cancer drugs to breast cancer cells.
Accessibility Tools